PIPOX

Chr 17

pipecolic acid and sarcosine oxidase

Also known as: LPIPOX

Enables L-pipecolate oxidase activity and sarcosine oxidase activity. Involved in L-lysine catabolic process to acetyl-CoA via L-pipecolate. Located in peroxisome. [provided by Alliance of Genome Resources, Jul 2025]

0
Active trials
0
Pathogenic / LP
0
ClinVar variants
9
Pubs (1 yr)
0.2
Missense Z
1.26
LOEUF
Clinical SummaryPIPOX
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.26LOEUF
pLI 0.000
Z-score 0.61
OE 0.86 (0.601.26)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.24Z-score
OE missense 0.96 (0.861.07)
224 obs / 234.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.86 (0.601.26)
00.351.4
Missense OE0.96 (0.861.07)
00.61.4
Synonymous OE0.90
01.21.6
LoF obs/exp: 19 / 22.1Missense obs/exp: 224 / 234.2Syn Z: 0.76
DN
DN
0.6648th %ile
GOF
0.4875th %ile
LOF
0.4039th %ile

The highest-scoring mechanism for this gene is dominant-negative.

DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

0 submitted variants in ClinVar

PIPOX · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Landmark / reviewRecent case evidence